Inspire Medical Systems Inc (INSP) — Capital Reinvestment Ratio
Latest as of March 2026:
0.76x
Inspire Medical Systems Inc (INSP) has a Capital Reinvestment Ratio of 0.76x as of March 2026, meaning it reinvests 1% of its operating cash flow ($12.85 Million) in capital expenditures ($9.73 Million). See cash generation quality of Inspire Medical Systems Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.76x
Capex / Operating Cash Flow
Operating Cash Flow
$12.85 Million
USD
Capital Expenditures
$9.73 Million
USD
Data as of
Mar 2026
Most recent filing
Inspire Medical Systems Inc Capital Reinvestment Ratio (2022–2025)
This chart tracks Inspire Medical Systems Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Inspire Medical Systems Inc (2022–2025)
Year-by-year Capital Reinvestment Ratio for Inspire Medical Systems Inc from 2022 to 2025. For live market cap and broader valuation context, see INSP market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | $116.98 Million | $38.50 Million | ▲ +9.6% |
| 2024 | 0.30x | $130.25 Million | $39.12 Million | ▼ -68.7% |
| 2023 | 0.96x | $24.65 Million | $23.63 Million | ▲ +21.9% |
| 2022 | 0.79x | $11.57 Million | $9.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow